tricalcium phosphate has been researched along with Influenza, Human in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hurst, BL; Morçӧl, T; Tarbet, EB | 1 |
| Ahn, SY; Jung, J; Ko, EJ; Le, CTT; Lee, DH; Lee, J | 1 |
| SALK, JE | 1 |
3 other study(ies) available for tricalcium phosphate and Influenza, Human
| Article | Year |
|---|---|
Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza A (H1N1) 2009 vaccine in mice.
Topics: Adjuvants, Immunologic; Aluminum Hydroxide; Animals; Antibodies, Viral; Calcium Phosphates; Dose-Response Relationship, Immunologic; Female; Hemagglutination Inhibition Tests; Humans; Immunogenicity, Vaccine; Immunoglobulin G; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Mice; Nanoparticles; Neutralization Tests; Off-Label Use; Orthomyxoviridae Infections; Pandemics; Vaccination; Vaccines, Inactivated | 2017 |
Protective and vaccine dose-sparing efficacy of Poly I:C-functionalized calcium phosphate nanoparticle adjuvants in inactivated influenza vaccination.
Topics: Adjuvants, Immunologic; Antibodies, Viral; Calcium Phosphates; Cytokines; Humans; Influenza Vaccines; Influenza, Human; Nanoparticles; Poly I-C; Toll-Like Receptor 3; Vaccines, Inactivated | 2022 |
Studies on the antigenicity, in man, of calcium phosphate adsorbed influenza virus; with comments on the question of dose of virus needed in vaccines for human use.
Topics: Antigens, Viral; Calcium Phosphates; Humans; Influenza Vaccines; Influenza, Human; Male; Orthomyxoviridae | 1947 |